The first published case of Diabetic Ketoacidosis-induced Takotsubo cardiomyopathy was in 2009. Our patient is the 1st reported case of Diabetic Ketoacidosis- (DKA-) induced Takotsubo cardiomyopathy (TC) in a patient with known hypertrophic cardiomyopathy (HOCM) in the United States. In the literature, there are only two examples linking DKA to TC; however, this report focuses on the biochemica...

We report a 23-year-old man with beta-thalassemia major and transfusional hemochromatosis, which manifested as diabetic ketoacidosis and hypogonadotropic hypogonadism. This unusual presentation of diabetic ketoacidosis in hemochromatosis has rarely been reported. Magnetic resonance imaging of the abdomen showed decreased signal intensity in the liver, spleen, and pancreas. In addition, the pitu...

An 18-year-old male with type 1 diabetes mellitus presented to the emergency department after one day of lethargy and vomiting. Physical examination revealed a dehydrated male with tachycardia and Kussmaul's respiration. There was subcutaneous emphysema in both supraclavicular regions. Chest auscultation revealed a positive Hamman's sign. Laboratory investigation was significant for metabolic a...

This paper provides an overview of euglycemic diabetic ketoacidosis (euDKA) associated with the use sodium-glucose co-transporter 2 (SGLT2) inhibitors. euDKA is a rare but potentially life-threatening complication that can occur in patients taking SGLT2 inhibitors, and its clinical presentation differs from traditional ketoacidosis. discusses epidemiology, pathophysiology, manifestations, diagn...

The authors propose a regimen for managing diabetic ketoacidosis in adults based on available evidence and their experience in the emergency department.

It is possible that SGLT2 inhibitors trigger euglycemic diabetic ketoacidosis in some patients. Possible mechanism of euglycemic DKA induced by SGLT2 inhibitors is illustrated.

OBJECTIVES: To evaluate the effect of two simultaneous protocols in reducing recovery time and assessment of adverse effects of different fluid replacement therapy in management of diabetic ketoacidosis. MATERIALS AND METHODS: In this randomized clinical trial study, two standard protocols were chosen to evaluate recovery time and incidence of DKA complications. RESULTS: 18 subjects who had ...